These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 22963896)

  • 1. Selective serotonin reuptake inhibitors and tricyclic antidepressants in the acute treatment of chronic depression and dysthymia: a systematic review and meta-analysis.
    von Wolff A; Hölzel LP; Westphal A; Härter M; Kriston L
    J Affect Disord; 2013 Jan; 144(1-2):7-15. PubMed ID: 22963896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: a meta-analysis.
    Arroll B; Macgillivray S; Ogston S; Reid I; Sullivan F; Williams B; Crombie I
    Ann Fam Med; 2005; 3(5):449-56. PubMed ID: 16189062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective serotonin reuptake inhibitors versus tricyclic antidepressants in young patients: a meta-analysis of efficacy and acceptability.
    Qin B; Zhang Y; Zhou X; Cheng P; Liu Y; Chen J; Fu Y; Luo Q; Xie P
    Clin Ther; 2014 Jul; 36(7):1087-1095.e4. PubMed ID: 24998011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SSRIS versus tricyclic antidepressants in depressed inpatients: a meta-analysis of efficacy and tolerability.
    Anderson IM
    Depress Anxiety; 1998; 7 Suppl 1():11-7. PubMed ID: 9597346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review: SSRIs and TCAs equally effective at treating chronic depression and dysthemia; SSRIs are associated with fewer adverse events than TCAs.
    Kocsis JH
    Evid Based Ment Health; 2013 Aug; 16(3):82. PubMed ID: 23604275
    [No Abstract]   [Full Text] [Related]  

  • 6. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.
    Anderson IM
    J Affect Disord; 2000 Apr; 58(1):19-36. PubMed ID: 10760555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressants versus placebo for depression in primary care.
    Arroll B; Elley CR; Fishman T; Goodyear-Smith FA; Kenealy T; Blashki G; Kerse N; Macgillivray S
    Cochrane Database Syst Rev; 2009 Jul; 2009(3):CD007954. PubMed ID: 19588448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoxetine versus other types of pharmacotherapy for depression.
    Magni LR; Purgato M; Gastaldon C; Papola D; Furukawa TA; Cipriani A; Barbui C
    Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD004185. PubMed ID: 24353997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefits and risks of pharmacotherapy for dysthymia: a systematic appraisal of the evidence.
    De Lima MS; Hotopf M
    Drug Saf; 2003; 26(1):55-64. PubMed ID: 12495364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs).
    Barbui C; Hotopf M; Freemantle N; Boynton J; Churchill R; Eccles MP; Geddes JR; Hardy R; Lewis G; Mason JM
    Cochrane Database Syst Rev; 2007 Jul; (3):CD002791. PubMed ID: 17636706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of SSRIs and newer antidepressants in severe depression: comparison with TCAs.
    Hirschfeld RM
    J Clin Psychiatry; 1999 May; 60(5):326-35. PubMed ID: 10362442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates.
    Montgomery SA; Henry J; McDonald G; Dinan T; Lader M; Hindmarch I; Clare A; Nutt D
    Int Clin Psychopharmacol; 1994; 9(1):47-53. PubMed ID: 8195583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analytical studies on new antidepressants.
    Anderson IM
    Br Med Bull; 2001; 57():161-78. PubMed ID: 11719915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are SSRIs better than TCAs? Comparison of SSRIs and TCAs: a meta-analysis.
    Steffens DC; Krishnan KR; Helms MJ
    Depress Anxiety; 1997; 6(1):10-8. PubMed ID: 9394870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct comparison of tricyclic and serotonin-reuptake inhibitor antidepressants in randomized head-to-head trials in acute major depression: Systematic review and meta-analysis.
    Undurraga J; Baldessarini RJ
    J Psychopharmacol; 2017 Sep; 31(9):1184-1189. PubMed ID: 28633600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants.
    Perry PJ
    J Affect Disord; 1996 Jun; 39(1):1-6. PubMed ID: 8835647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacy and acceptability of antidepressants in Parkinson's disease: a network meta-analysis.
    Liu J; Dong J; Wang L; Su Y; Yan P; Sun S
    PLoS One; 2013; 8(10):e76651. PubMed ID: 24098546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remission, dropouts, and adverse drug reaction rates in major depressive disorder: a meta-analysis of head-to-head trials.
    Machado M; Iskedjian M; Ruiz I; Einarson TR
    Curr Med Res Opin; 2006 Sep; 22(9):1825-37. PubMed ID: 16968586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and acceptability of selective serotonin reuptake inhibitors for the treatment of depression in Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials.
    Skapinakis P; Bakola E; Salanti G; Lewis G; Kyritsis AP; Mavreas V
    BMC Neurol; 2010 Jun; 10():49. PubMed ID: 20565960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of severe depression with the selective serotonin reuptake inhibitors.
    Schatzberg AF
    Depress Anxiety; 1996-1997; 4(4):182-9. PubMed ID: 9166650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.